导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 26.07% | 128/4773 |
| 近一周 | -2.27% | 1635/5462 |
| 近一月 | -10.17% | 4986/5421 |
| 近一季 | -12.06% | 3802/5209 |
| 近半年 | 20.96% | 128/4920 |
| 近一年 | 32.97% | 156/4366 |
| 近两年 | 173.28% | 110/2954 |
| 近三年 | 111.59% | 102/2253 |
| 成立以来 | 121.58% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.81% 3702/4961 |
99.68% 108/5312 |
- - |
- - |
| 2025 | 41.57% 731/4813 |
3.28% 1134/3635 |
-0.31% 2882/4076 |
48.01% 410/4524 |
-7.10% 3766/4813 |
| 2024 | 23.07% 354/3463 |
-10.77% 2379/2808 |
0.71% 556/3014 |
16.84% 1336/3129 |
17.22% 93/3463 |
| 2023 | -2.74% 604/2656 |
16.99% 182/2280 |
-7.03% 1760/2385 |
-9.25% 1790/2515 |
-1.47% 332/2655 |
| 2022 | -36.35% 1739/2207 |
-21.90% 1664/1919 |
-0.17% 1602/2016 |
-18.44% 1708/2113 |
0.10% 1542/2208 |
| 2021 | 26.46% 97/1822 |
-9.07% 1101/1255 |
37.77% 23/1330 |
-4.32% 700/1466 |
5.51% 288/1822 |
| 2020 | 49.94% 173/1250 |
9.39% 23/1028 |
29.36% 78/1067 |
-0.90% 1060/1164 |
6.93% 735/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 国泰CES半导体芯片行业ETF联接C VS. 长安沪深300非周期A(740101) |